Crosstalk between leptin and interleukin-1β abrogates negative inotropic effects in a model of chronic hyperleptinemia

Experimental Biology and Medicine

Volumn 236, Issue 11, 2011, Pages 1263-1273

  Radin, M Judith ^a   Holycross, J Bethany ^a   McCune, Sylvia A ^b   Altschuld, Ruth A ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Cardiac myocytes; Interleukin 1 ; Leptin; SHHF rat; Signal transducers and activators of transcription; Suppressors of cytokine signaling

Indexed keywords

CALCIUM; INTERLEUKIN 1BETA; JANUS KINASE; LEPTIN; STAT3 PROTEIN; STAT5 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CHRONIC DISEASE; CONTROLLED STUDY; HEART MUSCLE CELL; HORMONE ACTION; HYPERLEPTINEMIA; INOTROPISM; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; HYPERTENSION; INTERLEUKIN-1BETA; LEPTIN; MALE; MYOCYTES, CARDIAC; RATS; RATS, INBRED STRAINS; RECEPTORS, LEPTIN; SIGNAL TRANSDUCTION;

RATTUS;

EID: 80055109957     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2011.011144     Document Type: Article

References (54)

1. Sweeney G. Cardiovascular effects of leptin. Nat Rev Cardiol 2010;7:22-9
2. Radin MJ, Holycross BJ, Dumitrescu C, Kelley R, Altschuld RA. Leptin modulates the negative inotropic effect of interleukin-1b in cardiac myocytes. Mol Cell Biochem 2008;315:179-84
3. Nickola MW, Wold LE, Colligan PB, Wang G-J, Samson WK, Ren J. Leptin attenuates cardiac contraction in rat ventricular myocytes. Role of NO. Hypertension 2000;36:501-5
4. Martin SS, Qasim A, Reilly MP. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol 2008;52:1201-10
5. Trayhurn P. Adipose tissue in obesity - an inflammatory issue. Endocrinology 2005;146:1003-5
6. Bujak M, Frangogiannis NG. The role of IL-1 in the pathogenesis of heart disease. Arch Immunol Ther Exp 2009;57:165-76
7. Long CS. The role of interleukin-1 in the failing heart. Heart Fail Rev 2001;6:81-94
8. Favory R, Lancel S, Marchetti P, Mordon S, Chopin C, Formstecher P, Neviere R. Endotoxin-induced myocardial dysfunction: evidence for a role of sphingosine production. Crit Care Med 2004;32:495-501
9. Schreur KD, Liu S. Involvement of ceramide in inhibitory effect of IL-1 beta on L-type calcium current in adult rat ventricular myocytes. Am J Physiol Heart Circ Physiol 1997;272:H2591-8
10. Schulz R, Panas DL, Catena R, Moncada S, Olley PM, Lopaschuk GD. The role of nitric oxide in cardiac depression induced by interleukin-1-beta and tumour necrosis factor-alpha. Br J Pharmacol 1995;114:27-34
11. Hekerman P, Zeidler J, Bamberg-Lemper S, Knobelspies H, Lavens D, Tavernier J, Joost HG, Becker W. Pleiotropy of leptin receptor signalling is defined by distinct roles of the intracellular tyrosines. FEBS J 2005;272:109-19
12. Bjørbaek C, El-Haschimi K, Frantz JD, Flier JS. The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem 1999;274:30059-65
13. Bjørbaek C, Elmquist JK, Frantz JD, Shoelson SE, Flier JS. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1998;1:619-25
14. Bruun C, Heding PE, Rønn SG, Frobøse H, Rhodes CJ, Mandrup-Poulsen T, Billestrup N. Suppressor of cytokine signalling-3 inhibits tumor necrosis factor-alpha induced apoptosis and signalling in beta cells. Mol Cell Endocrinol 2009;311:32-8
15. Rønn SG, Börjesson A, Bruun C, Heding PE, Frobøse H, Mandrup-Poulsen T, Karlsen AE, Rasschaert J, Sandler S, Billestrup N. Suppressor of cytokine signalling-3 expression inhibits cytokine-mediated destruction of primary mouse and rat pancreatic islets and delays allograft rejection. Diabetologia 2008;51:1873-82
16. Karlsen AE, Rønn SG, Lindberg K, Johannesen J, Galsgaard ED, Pociot F, Nielsen JH, Mandrup-Poulsen T, Nerup J, Billestrup N. Suppressor of cytokine signaling 3 (SOCS-3) protects beta-cells against interleukin-1beta- and interferon-gamma-mediated toxicity. Proc Natl Acad Sci USA 2001;98:12191-6
17. Rakatzi I, Mueller H, Ritzeler O, Tennagels N, Eckel J. Adiponectin counteracts cytokine- and fatty acid-induced apoptosis in the pancreatic beta-cell line INS-1. Diabetologia 2004;47:249-58
18. Shimabukuro M, Koyama K, Lee Y, Unger RH. Leptin- or troglitazone-induced lipopenia protects islets from interleukin 1beta cytotoxicity. Clin Invest 1997;100:1750-4
19. Radin MJ, Holycross BJ, Hoepf TM, McCune SA. Increased salt sensitivity secondary to leptin resistance in SHHF rats is mediated by endothelin. Mol Cell Biochem 2003;242:57-63
20. McCune SA, Radin MJ, Jenkins JE, Chu Y, Park S, Peterson RG. SHHF/Mcc-facp rat model: effects of gender and genotype on age of expression of metabolic complications and congestive heart failure and on response to drug therapy. In: Shafrir E, ed. Lessons from Animal Diabetes V. Chapter 23. London: Smith-Gorden, 1996:255-70
21. McCune SA, Jenkins JE, Stills HF, Park S, Radin MJ, Jurin RR, Hamlin RE. Renal and heart function in the SHHF/Mcc-cp rat. In: Shafrir E, ed. Frontiers in Diabetes Research. Lessons from Animal Diabetes III. London: Smith Gordon, Inc, 1990:397-401
22. Ishizuka T, Ernsberger P, Liu S, Bedol D, Lehman TM, Koletsky RJ, Friedman JE. Phenotypic consequences of a nonsense mutation in the leptin receptor gene (fak) in obese spontaneously hypertensive Koletsky rats (SHROB). J Nutr 1998;128:2299-306
23. Radin MJ, Chu YY, Hoepf T, McCune SA. Treatment of obese female and male SHHF/Mcc-facp rats with antihypertensive drugs, nifedipine and enalapril: effects on body weight, fat distribution, insulin resistance and systolic pressure. Obes Res 1993;1:433-42
24. Bergman MR, Holycross BJ. Pharmacological modulation of myocardial tumor necrosis factor a production by phosphodiesterase inhibitors. J Pharmacol Exp Ther 1996;279:247-54
25. Houle MS, Altschuld RA, Billman GE. Enhanced in vivo and in vitro contractile responses to b2-adrenergic receptor stimulation in dogs susceptible to lethal arrhythmias. J Appl Physiol 2001;91:1627-37
26. Radin MJ, Holycross BJ, Hoepf TM, McCune SA. Salt induced cardiac hypertrophy is independent of blood pressure and endothelin in obese heart failure-prone SHHF rats. Clin Expt Hyperten 2008;30:541-52
27. Morgan DA, Thedens DR, Weiss R, Rahmouni K. Mechanisms mediating renal sympathetic activation to leptin in obesity. Am J Physiol Regul Integr Comp Physiol 2008;295:R1730-6
28. Rahmouni K, Morgan DA, Morgan GM, Mark AL, Haynes WG. Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes 2005;54:2012-8
29. Correia ML, Haynes WG, Rahmouni K, Morgan DA, Sivitz WI, Mark AL. The concept of selective leptin resistance: evidence from agouti yellow obese mice. Diabetes 2002;51:439-42
30. Prabhu SD. Cytokine-induced modulation of cardiac function. Circ Res 2004;95:1140-53
31. Faggioni R, Fantuzzi G, Gabay C, Moser A, Dinarello CA, Feingold KR, Grunfeld C. Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am J Physiol 1999;276:R136-42
32. Faggioni R, Moser A, Feingold KR, Grungeld C. Reduced leptin levels in starvation increase susceptibility to endotoxic shock. Am J Pathol 2000;156:1781-7
33. Yu X, Kennedy RH, Liu SJ. JAK2/STAT3, not ERK1/2, mediates interleukin-6-induced activation of inducible nitric-oxide synthase and decrease in contractility of adult ventricular myocytes. J Biol Chem 2003;278:16304-9
34. Bulcao CF, D'Souza KM, Malhotra R, Staron M, Duffy JY, Pandalai PK, Jeevanandam V, Akhter SA. Activation of JAK-STAT and nitric oxide signaling as a mechanism for donor heart dysfunction. J Heart Lung Transplant 2010;29:346-51
35. Emanuelli B, Glondu M, Filloux C, Peraldi P, Van Obberghen E. The potential role of SOCS-3 in the interleukin-1beta-induced desensitization of insulin signaling in pancreatic beta-cells. Diabetes 2004;53(Suppl. 3):S97-103
36. Bjørbaek C, Kahn BB. Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 2004;59:305-31
37. Wold LE, Relling DP, Duan J, Norby FL, Ren J. Abrogated leptin-induced cardiac contractile response in ventricular myocytes under spontaneous hypertension. Role of JAK/STAT pathway. Hypertension 2002;39:69-74
38. Abe Y, Ono K, Kawamura T, Wada H, Kita T, Shimatsu A, Hasegawa K. Leptin induces elongation of cardiac myocytes and causes eccentric left ventricular dilatation with compensation. Am J Physiol Heart Circ Physiol 2007;292:H2387-96
39. Ren J, Dong F, Cai G-J, Zhao P, Numm JM, Wold LE, Pei J. Interaction between age and obesity on cardiomyocyte contractile function: role of leptin and stress signaling. PLos ONE 2010;5:e10085. doi: 10.1371/journal.pone.0010085
40. Zabolotny JM, Bence-Hanulec KK, Stricker-Krongrad A, Haj F, Wang Y, Minokoshi Y, Kim YB, Elmquist JK, Tartaglia LA, Kahn BB, Neel BG. PTP1B regulates leptin signal transduction in vivo. Dev Cell 2002;4:489-95
41. Ali MI, Ketsawatsomkron P, Belin de Chantemele EJ, Mintz JD, Muta K, Salet C, Black SM, Tremblay ML, Fulton DJ, Marrero MB, Stepp DW. Deletion of protein tyrosine phosphatase 1b improves peripheral insulin resistance and vascular function in obese, leptin-resistant mice via reduced oxidant tone. Circ Res 2009;105:1013-22
42. Mohammad A, Wang J, McNeill JH. Bis(maltolato)oxovanadium(IV) inhibits the activity of PTP1B in Zucker rat skeletal muscle in vivo. Mol Cell Biochem 2002;229:125-8
43. Aoki N, Matsuda T. A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b. J Biol Chem 2000;275:39718-26
44. Morris DL, Rui L. Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrin Metab 2009;297:E1247-59
45. Sato K, Ozaki K, Oh I, Meguro A, Hatanaka K, Nagai T, Muroi K, Ozawa K. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 2007;109:228-34
46. Eriksson U, Egermann U, Bihl MP, Gambazzi F, Tamm M, Holt PG, Bingisser RM. Human bronchial epithelium controls TH2 responses by TH1-induced, nitric oxide-mediated STAT5 dephosphorylation: implications for the pathogenesis of asthma. J Immunol 2005;175:2715-20
47. Mazzoni A, Bronte V, Visintin A, Spitzer JH, Apolloni E, Serafini P, Zanovello P, Segal DM. Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. J Immunol 2002;168:689-95
48. Bingisser RM, Tilbrook PA, Holt PG, Kees UR. Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway. J Immunol 1998;160:5729-34
49. Wurzinger B, Dü nser MW, Wohlmuth C, Deutinger MC, Ulmer H, Torgersen C, Schmittinger CA, Grander W, Hasibeder WR. The association between body-mass index and patient outcome inseptic shock: a retrospective cohort study. Wien Klin Wochenschr 2010;122:31-6
50. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004;92:347-55
51. Xuan YT, Guo Y, Han H, Zhu Y, Bolli R. An essential role of the JAK-STAT pathway in ischemic preconditioning. Proc Natl Acad Sci USA 2001;98:9050-5
52. Hattori R, Maulik N, Otani H, Zhu L, Cordis G, Engelman RM, Siddiqui MA, Das DK. Role of STAT3 in ischemic preconditioning. J Mol Cell Cardiol 2001;33:1929-36
53. Yamaura G, Turoczi T, Yamamoto F, Siddqui MA, Maulik N, Das DK. STAT signaling in ischemic heart: a role of STAT5A in ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003;285:H476-82
54. Jacoby JJ, Kalinowski A, Liu MG, Zhang SS, Gao Q, Chai GX, Ji L, Iwamoto Y, Li E, Schneider M, Russell KS, Fu XY. Cardiomyocyte restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age. Proc Natl Acad Sci USA 2003;100:12929-34